FREMONT, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS) announced today that it will announce second quarter ended June 30, 2015 financial results after the market close and host a conference call and webcast on Wednesday, August 5, 2015.
|Conference Call & Webcast|
|Wednesday, August 5, 2015 @ 5:00pm Eastern Time|
|Replays available until August 19, 2015|
WaferGen Bio-systems, Inc. is a life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesign™ Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TE™ System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Seq-Ready™ TE System, powered by SmartChipTM massively-parallel singleplex PCR technology, is an innovative one-step target enrichment and library preparation solution. The Company now also offers the Apollo 324™ product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster and cheaper genetic analysis based on Next-Gen Sequencing and Real-Time PCR. In addition, WaferGen has established proof-of-concept for its single cell technology, which is based on the Company's SmartChip™ platform. WaferGen's scientists have successfully isolated single cells and produced excellent results in downstream processing of these individual cells, including RNA sequencing.
For additional information, please see http://www.wafergen.com